|
|
|
Grupo IMO Hosts Symposium on Use of TomoTherapy for Stereotactic Radiosurgery and Stereotactic Body Radiation Procedures : Experts Detail Hi·Art® Platform Advantages for Treatment of Brain, Lung, Pancreatic and Metastatic Cancers
Posted By: Anonymous | Posted On: Oct 14,2008 18:30 pm | View: 11
TomoTherapy Incorporated (NASDAQ: TOMO) announced today that Grupo IMO of Madrid, Spain, recently hosted a symposium on the clinical use of the Hi·Art® treatment system for stereotactic radiosurgery (SRS) and stereotactic body radiation therapy (SBRT). Symposium speakers highlighted the Hi·Art system’s inherent suitability for stereotactic procedures with respect to dose conformality and homogeneity; presented clinical work on a variety of intra- and extracranial cases; and discussed future research goals.
Read More: http://www.prweb.com/releases/grupo_imo/stereotactic_body/prweb1480034.htm
|
|
|
|